OPPI elects A Vaid­heesh as pres­i­dent

BioSpectrum (Asia) - - People News -

The Or­gan­i­sa­tion of Phar­ma­ceu­ti­cal Pro­duc­ers of In­dia (OPPI), which rep­re­sents re­search-based phar­ma­ceu­ti­cal com­pa­nies in In­dia, has unan­i­mously elected A Vaid­heesh, vice pres­i­dent, South Asia & man­ag­ing di­rec­tor, Glax­oSmithK­line Phar­ma­ceu­ti­cals as pres­i­dent for the year 2017-18. He takes over from Dr Shailesh Ayyan­gar, man­ag­ing di­rec­tor, In­dia & Head - South Asia, Sanofi who held this po­si­tion since 2013. The four elected vice pres­i­dents are Sharad Tyagi, man­ag­ing di­rec­tor, Boehringer In­gel­heim; San­jiv Na­van­gul, man­ag­ing di­rec­tor, Janssen In­dia (Phar­ma­ceu­ti­cal Com­pa­nies of John­son & John­son Ltd); S Srid­har, man­ag­ing di­rec­tor, Pfizer Ltd and Anand Nam­biar, man­ag­ing di­rec­tor, Merck In­dia Ltd. The mem­ber com­pa­nies of OPPI have played a very im­por­tant and re­spon­si­ble role in col­lab­o­rat­ing with the Gov­ern­ment and var­i­ous stake­holder groups to en­sure that high qual­ity, in­no­va­tive and essen­tial medicines are avail­able at af­ford­able prices across In­dia. Along with an in­clu­sive ecosys­tem, in the com­ing years, health­care fi­nanc­ing will also play its role in im­prov­ing ac­cess to health­care.

Newspapers in English

Newspapers from India

© PressReader. All rights reserved.